Xradia
Latest round
- Series D
Last raised
- Mar 2007
Total raised
- $5M
Investors
- 2
About Xradia
Founded in 2000 and headquartered in Pleasanton, US, Xradia focuses on developing X-ray imaging technologies. The company was acquired by Carl Zeiss Group in June 2013 for an undisclosed sum.Xradia provides cutting-edge X-ray microscopy systems designed for high-resolution imaging of materials and biological samples. Following the acquisition by Carl Zeiss Group, the company aims to release new imaging solutions tailored for advanced research applications. Specific details on the release dates for these new products have not been disclosed. Additionally, the company is exploring opportunities to expand into new geographic regions to increase its customer base and market penetration.
Who invested in Xradia
2 investors across 1 round
See all investors in Xradia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 7, 2007
Amount
$5M
Investors
Questions about Xradia
Who invested in Xradia?
Xradia has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xradia raised?
Xradia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xradia last raise money?
Xradia's most recent round on record is a Series D, in Mar 2007.
What does Xradia do?
Founded in 2000 and headquartered in Pleasanton, US, Xradia focuses on developing X-ray imaging technologies.
Where is Xradia headquartered?
Xradia is headquartered in Pleasanton, US.
Which VCs invest in companies like Xradia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Xradia's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Xradia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.